USPTO serial 79294950
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
DK-3460 Birkerød, DK
DK-3460 Birkerød, DK
DK-3460 Birkerød, DK
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Lasers and laser amplifiers for non-medical use, in particular for applications within manufacturing, material processing, optical pumping and LIDAR; lasers for non-medical use, in particular lasers providing femtosecond, picosecond and nanosecond pulses, high-power lasers, narrow linewidth lasers and fiber lasers; laser amplifiers for non-medical use, in particular laser amplifiers based on optical fiber amplifier modules; modules for second-harmonic generation in the nature of power amplifiers; amplifier modules, namely, power amplifiers in the nature of modules for amplifying light, in particular for amplifying laser light; amplifier modules, namely, integrated circuit modules in the nature of power amplifiers based on optical fibers, in particular photonic crystal fibers including rare earth dopants such as ytterbium, erbium, or tellurium; amplifier modules, namely, integrated circuit modules in the nature of power amplifiers for amplification of femtosecond, picosecond and nanosecond pulses; amplifier modules, namely, integrated circuit modules in the nature of power amplifiers for original equipment manufacturer integration and scientific laboratory setups; active optical fibers, in particular rare earth doped double-clad optical fibers; amplifier medium in the nature of optical fibers for high power amplifiers; downloadable and recorded computer programs and software for controlling a laser or a laser amplifier | ACTIVE | — |
| 010 | Lasers and laser amplifiers for medical use, in particular for applications within optogenetics, ophthalmology or biomedical imaging; pulsed lasers for medical use, in particular lasers providing femtosecond, picosecond and nanosecond pulses; high-power lasers for medical use; fiber lasers for medical use; narrow linewidth lasers for medical use; modules, namely, integrated circuit modules in the nature of power amplifiers specially adapted for use with medical lasers for second-harmonic generation for medical use; laser amplifiers for medical use, in particular laser amplifiers based on optical fiber amplifier modules; amplifier modules, namely, integrated circuit modules specially adapted for use with medical lasers for amplifying light, in particular for amplifying laser light, all the aforesaid for medical use; amplifier modules, namely, integrated circuit modules specially adapted for use with medical lasers, based on optical fibers, in particular photonic crystal fibers including rare earth dopants such as ytterbium, erbium, or tellurium; all the aforesaid for medical use; amplifier modules, namely, integrated circuit modules in the nature of power amplifiers specially adapted for use with medical lasers for amplification of femtosecond, picosecond and nanosecond pulses, all the aforesaid for medical use; amplifier modules, namely, integrated circuit modules specially adapted for use with medical lasers for original equipment manufacturer integration and scientific laboratory setups, all the aforesaid for medical use; active optical fibers specially adapted for use with medical lasers, in particular rare earth doped double-clad optical fibers; amplifier medium in the nature of optical fibers for high power amplifiers specially adapted for use with medical lasers, all the aforesaid for medical use; amplifier modules, namely, integrated circuit modules in the nature of power amplifiers specially adapted for use with medical lasers for medical use | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 7, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 20, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 20, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 20, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 10, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 22, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 22, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 5, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 5, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 1, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 20, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 20, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 9, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 30, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 30, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 16, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 21, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 21, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 21, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 13, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 24, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 24, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 6, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 5, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 3, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 10, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 6, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 1, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |